A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Fecha de publicación
2011Título de revista
INVESTIGATIONAL NEW DRUGS
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)